Music intensifies effects of anti-hypertensive medication

In addition to remembering to take the medication prescribed by their cardiologists at the right times and going to the trouble of making healthy lifestyle changes, patients with high blood pressure (hypertension) can include a pleasing beneficial activity in routine treatment of the disease thanks to the discovery that listening to music significantly enhances the effect of anti-hypertensive drugs.

According to a study conducted by researchers on the Marília campus of São Paulo State University (UNESP) in Brazil, in collaboration with colleagues at Juazeiro do Norte College (FJN) and ABC Medical School (FMABC), also in Brazil, and Oxford Brookes University in the UK, music intensifies the beneficial effects of medication a short time after it is taken to control high blood pressure.

The results of the study, which was part of a project supported by the São Paulo Research Foundaiton - FAPESP, were published in Scientific Reports.

"We observed that music improved heart rate and enhanced the effect of anti-hypertensives for about an hour after they were administered," said Vitor Engrácia Valenti, a professor in the Speech Language Pathology Department of UNESP Marília's School of Philosophy & Sciences (FFC) and coordinator of the study.

A few years ago, the researchers at UNESP Marília began studying the effects of music on the heart in conditions of stress. One of their findings is that classical music tends to lower heart rate.

"We've observed classical music activating the parasympathetic nervous system and reducing sympathetic activity," said the principal investigator of the FAPESP-funded project. The sympathetic and parasympathetic nervous systems constitute the autonomic nervous system, which maintains homeostasis. The sympathetic nervous system accelerates heart rate, constricts blood vessels and raises blood pressure. The parasympathetic nervous system controls the body at rest, slowing the heart, lowering blood pressure, and stabilizing blood sugar and adrenaline.

The researchers followed up this finding by measuring the effect of musical stimulation on heart rate variability in ordinary situations such as treatment for high blood pressure, in which music therapy has been studied as a complementary intervention.

"Previous research showed music therapy having a significant positive effect on blood pressure in hypertensive patients," Valenti said. "But it wasn't clear if music could influence the effects of medication on heart rate variability and on systolic and diastolic blood pressure."

The researchers performed an experiment to measure the effects of musical auditory stimulus associated with anti-hypertensive medication on heart rate and blood pressure in 37 patients with well-controlled hypertension. The subjects had been undergoing anti-hypertensive treatment for between six months and a year. Measurements were taken on two random days with a gap of 48 hours.

On one day, after taking their usual oral anti-hypertensive medication, patients listened to instrumental music via earphones for 60 minutes at the same volume. As control, on the other day, they underwent the same research protocol, but the earphones were not turned on.

Heart rate variability was measured at rest and at 20, 40 and 60 minutes after oral medication. Several statistical and mathematical techniques were used to detect differences between heart rates at different times, with high precision and sensitivity.

Analysis of the data showed heart rate diminishing significantly 60 minutes after medication when patients listed to music in the period. Heart rate did not fall as significantly when they did not listen to music.

Blood pressure also responded more strongly to medication when they listened to music.

"We found that the effect of anti-hypertension medication on heart rate was enhanced by listening to music," Valenti said.

One of the hypotheses raised by the researchers is that music stimulates the parasympathetic nervous system, increases gastrointestinal activity and accelerates absorption of anti-hypertensive medication, intensifying its effects on heart rate.

Eli Carlos Martiniano, Milana Drumond Ramos Santana, Érico Luiz Damasceno Barros, Maria do Socorro da Silva, David Matthew Garner, Luiz Carlos de Abreu, Vitor E Valenti.
Musical auditory stimulus acutely influences heart rate dynamic responses to medication in subjects with well-controlled hypertension.
Scientific Reportsvolume 8, Article number: 958 (2018). doi: 10.1038/s41598-018-19418-7.

Most Popular Now

Chemists characterize the fatal fungus among us

Life-threatening fungal infections affect more than two million people worldwide. Effective antifungal medications are very limited. Until now, one of the major challenge...

FDA approves first cancer drug through new oncolog…

The U.S. Food and Drug Administration today approved Kisqali (ribociclib) in combination with an aromatase inhibitor for the treatment of pre/perimenopausal or postmenopa...

Discovery of kidney cancer driver could lead to ne…

University of North Carolina Lineberger Comprehensive Cancer Center scientists have uncovered a potential therapeutic target for kidney cancers that have a common genetic...

The immune system: T cells are built for speed

Without T cells, we could not survive. They are a key component of our immune system and have highly sensitive receptors on their surface that can detect pathogens. The e...

Pfizer initiates pivotal Phase 3 program for inves…

Pfizer Inc. (NYSE:PFE) and Spark Therapeutics (NASDAQ:ONCE) announced today that Pfizer initiated a Phase 3 open-label, multi-center, lead-in study (NCT03587116) to evalu...

FDA approves first targeted treatment for patients…

The U.S. Food and Drug Administration today approved Tibsovo (ivosidenib) tablets for the treatment of adult patients with relapsed or refractory acute myeloid leukemia (...

Sanofi and REVOLUTION Medicines launch global part…

Sanofi and REVOLUTION Medicines, Inc. today announced an exclusive worldwide partnership to develop and commercialize targeted therapies, based on the biology of the cell...

Novartis renews drug donation of Egaten® (triclabe…

Novartis reaffirms its commitment to the fight against liver fluke (fascioliasis), signing a renewed memorandum of understanding with the World Health Organization (WHO) ...

Women and older people under-represented in drug t…

Trying to determine how best to treat a patient, doctors often look to randomized clinical trials to guide their choice of what drug to prescribe. One of the most common ...

New findings suggest allergic responses may protec…

The components of the immune system that trigger allergic reactions may also help protect the skin against cancer, suggest new findings. The research, led by Imperial Col...

FDA grants Breakthrough Therapy Designation for Ro…

Roche (SIX: RO, ROG; OTCQX: RHHBY) announced that the U.S. Food and Drug Administration (FDA) has granted Breakthrough Therapy Designation for Tecentriq® (atezolizumab) i...

Novartis marks a new era for migraine patients wit…

Novartis announced today that the European Commission (EC) approved Aimovig® (erenumab) for the prevention of migraine in adults experiencing four or more migraine days p...